Archive for September, 2008
« Previous EntriesPfizer to focus on more profitable diseases
Tuesday, September 30th, 2008Pfizer to focus on more profitable diseases
Pfizer, the world’s largest drug maker, is ending early-stage development of treatments for a range of illnesses from obesity to heart disease to focus on more profitable diseases.
Pfizer expects to spend $7.2 billion to $7.5 billion on research and development this year, a huge budget for the industry. “Even […]
U.S. or Europe: Whose Kids Are More Medicated?
Saturday, September 27th, 2008U.S. or Europe: Whose Kids Are More Medicated?
American Children Three Times More Likely to Be Prescribed Antidepressants, Stimulants
American children are about three times more likely to be prescribed psychotropic medication as are children in Western Europe, according to a new study published in Child and Adolescent Psychiatry and Mental Health. Psychotropic drugs are drugs that […]
New Diabetes Drug Works Well in Trial
Thursday, September 25th, 2008New Diabetes Drug Works Well in Trial
One of a new class of diabetes drugs has done well in a trial conducted to help bring it to market, researchers report.
The drug, liraglutide, is a laboratory-made version of glucagon-like peptide-1 (GLP-1), a hormone produced by the body. Several members of the GLP-1 family are in clinical […]
Health Insurance Costs Increased Again
Thursday, September 25th, 2008Health Insurance Costs Increased Again
It seems that Americans are fighting against another financial crisis: the unpaid medical bills. Two studies released Wednesday were made by the Kaiser Family Foundation and the Center for Studying Health System Change and had been completed earlier this year before the financial markets reached their current state of crisis.
Employer-based health […]
FDA Approves Nasacort AQ(R) Nasal Spray For Children Aged 2 - 5 Years Old
Wednesday, September 24th, 2008FDA Approves Nasacort AQ(R) Nasal Spray For Children Aged 2 - 5 Years Old
Sanofi-aventis announced the U.S. Food and Drug Administration (FDA) has approved Nasacort AQ Nasal Spray (triamcinolone acetonide) for children aged 2 - 5 years old for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis.
The FDA based its approval […]
